2021-2022 Regular Session • US Congress Legislature
HB8641: Orphan Drug COVID–19 Mitigation Act of 2022
Legislative Summary
To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic for the development of orphan drugs, and for other purposes.
Bill History
8/2/2022
Introduced in House
House of Representatives
8/2/2022
Referred to the House Committee on Energy and Commerce.
House of Representatives
Status Information
Current Status
Introduced(8/2/2022)
Chamber
House of Representatives
Committee
Energy And Commerce(House of Representatives)
Sponsors
Democrat: 3
Republican: 1
Primary Sponsor
Josh Gottheimer
Democrat